D.A. Davidson & CO. Cuts Holdings in Nutrien Ltd. (NYSE:NTR)

D.A. Davidson & CO. lessened its position in shares of Nutrien Ltd. (NYSE:NTRFree Report) by 20.2% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 133,630 shares of the company’s stock after selling 33,775 shares during the period. D.A. Davidson & CO.’s holdings in Nutrien were worth $6,422,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in NTR. Central Pacific Bank Trust Division purchased a new position in shares of Nutrien in the 3rd quarter valued at $28,000. Family Firm Inc. purchased a new position in Nutrien in the second quarter valued at about $32,000. Trust Co. of Vermont lifted its stake in shares of Nutrien by 50.0% during the second quarter. Trust Co. of Vermont now owns 900 shares of the company’s stock worth $46,000 after purchasing an additional 300 shares in the last quarter. Andra AP fonden purchased a new stake in shares of Nutrien in the second quarter worth about $51,000. Finally, Oakworth Capital Inc. acquired a new stake in shares of Nutrien in the second quarter valued at about $52,000. 63.10% of the stock is currently owned by institutional investors and hedge funds.

Nutrien Stock Up 0.4 %

Shares of NYSE:NTR opened at $46.09 on Thursday. The company’s fifty day moving average is $47.97 and its two-hundred day moving average is $49.91. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.82 and a current ratio of 1.27. Nutrien Ltd. has a 1-year low of $44.65 and a 1-year high of $60.87. The stock has a market capitalization of $22.76 billion, a price-to-earnings ratio of 30.93, a price-to-earnings-growth ratio of 1.64 and a beta of 0.82.

Nutrien (NYSE:NTRGet Free Report) last released its quarterly earnings data on Wednesday, November 6th. The company reported $0.39 earnings per share for the quarter, missing the consensus estimate of $0.43 by ($0.04). Nutrien had a return on equity of 6.99% and a net margin of 2.79%. The business had revenue of $5.35 billion for the quarter, compared to analyst estimates of $5.26 billion. During the same quarter last year, the company earned $0.35 EPS. Nutrien’s revenue was down 5.0% compared to the same quarter last year. Equities analysts anticipate that Nutrien Ltd. will post 3.56 EPS for the current year.

Nutrien Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 17th. Investors of record on Tuesday, December 31st will be given a dividend of $0.939 per share. The ex-dividend date of this dividend is Tuesday, December 31st. This represents a $3.76 dividend on an annualized basis and a yield of 8.15%. This is a positive change from Nutrien’s previous quarterly dividend of $0.54. Nutrien’s payout ratio is currently 144.97%.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on the company. Royal Bank of Canada reissued an “outperform” rating and set a $60.00 price target on shares of Nutrien in a research report on Friday, September 20th. Scotiabank decreased their target price on shares of Nutrien from $66.00 to $59.00 and set a “sector outperform” rating for the company in a research note on Monday, August 12th. The Goldman Sachs Group lowered shares of Nutrien from a “buy” rating to a “neutral” rating and lowered their price target for the company from $69.00 to $53.00 in a report on Tuesday, September 10th. Wells Fargo & Company lowered shares of Nutrien from an “overweight” rating to an “equal weight” rating and cut their price objective for the stock from $62.00 to $50.00 in a report on Tuesday, September 24th. Finally, Hsbc Global Res downgraded Nutrien from a “hold” rating to a “moderate sell” rating in a research note on Friday, August 2nd. Three research analysts have rated the stock with a sell rating, six have assigned a hold rating and ten have given a buy rating to the stock. According to data from MarketBeat.com, Nutrien currently has an average rating of “Hold” and a consensus target price of $60.33.

Read Our Latest Report on NTR

Nutrien Company Profile

(Free Report)

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.

Featured Stories

Institutional Ownership by Quarter for Nutrien (NYSE:NTR)

Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.